Business / Finance

RSS

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Over 2,800 cases, representing a 31% increase, added to BGI Genomics-led CardioGen's hereditary cardiovascular disease gene data.

From BGI Genomics 1 Jun 2023

eMolecules acquires Specs Compound Handling B.V.

Combination expands footprint offering a global one-stop shop for streamlined chemical compound procurement and management services for drug discovery chemistry researchers.

From eMolecules 26 May 2023

bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

Researchers can now order their mutation of choice in bit.bio’s opti-oxTM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated into drug discovery workflows.

From bit.bio 24 May 2023

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

A collaborative agreement between Izon Science and Agarose Bead Technologies (ABT) offers exceptional opportunities to develop solutions that aid in advancing EV research into clinical settings.

From Agarose Bead Technologies 16 May 2023

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

Affordable two-chip Beacon Select system to broaden customer access to innovative high throughput, function-first antibody discovery capabilities.

From Bruker Cellular Analysis 16 May 2023

H.E.L Group makes senior appointments as it continues to scale globally

Hasan Hallaq, PhD appointed as European Sales Director, Victoria Ordsmith joins as Director of Marketing and Sarennah Longworth-Cook promoted Director of People.

From H.E.L Group 16 May 2023

LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

Through a recent platform demonstration project, LabGenius’ machine learning-driven lead optimisation capability delivered dozens of novel T-cell engagers with best-in-class killing selectivity.

From LabGenius 16 May 2023

Vector Biolabs expands viral vector manufacturing capacity and adds to QC capabilities

Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing demand.

12 May 2023

Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology

Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand.

12 May 2023

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges

From Revvity 9 May 2023

Global Access Diagnostics (GADx) welcomes new leadership

GADx announces today that Mr Mark Davis is stepping down as CEO and co-founder after 20 years of unwavering service, having created the organisation Mologic Ltd in June 2003 alongside his father and industry leader, Prof. Paul Davis.

From Global Access Diagnostics 5 May 2023

CELLINK Unveils Third Generation LUMEN X – The New Standard for DLP Bioprinting

CELLINK today announced the release of the third generation of their LUMEN X™ product – the new standard for benchtop DLP bioprinting.

From CELLINK 5 May 2023

Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Kenneth Hitchner, BA MBA, as Chairman of its Board of Directors.

From Sphere Fluidics 2 May 2023

MGI and South Australian Genomics Centre Introduce DNBSEQ-T7 to Supercharge Genomics Research in Australia

Brisbane, Australia 27th April 2023 - MGI and South Australian Genomics Centre (SAGC) are proud to announce their joint efforts to advance genomics research in Australia by introducing the country's first commercial ultra-high throughput sequencer DNBSEQ-T7*, through MGI's local distributor Decode Science.

From MGI 27 Apr 2023

MGI Announces New Customer Experience Center in South Korea with BMS

Cheonan, South Korea, 26 April 2023 – MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today celebrated the opening of its Customer Experience Center (CEC) in South Korea. In partnership with one of the country’s leading companies in life science technology, BMS (Bio-Medical science Co., Ltd.), the new CEC based in Cheonan aims to provide local customers and partners with the first-hand access to MGI's cutting-edge products.

From MGI 27 Apr 2023

MGI Secured First Corporate Order of Ultra-high Throughput Sequencer DNBSEQ-T20×2*

Shanghai, China, April 25th, 2023 — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, announced its partnership with Shanghai-based JMDNA Biomedical Technology Co., Ltd. (“JMDNA”) for DNBSEQ-T20×2 (“T20”), a sequencer that broke records for its ultra-high throughput and cost-efficiency. This was the first corporate order of the T20 sequencer that MGI has secured worldwide.

From MGI 27 Apr 2023

Business / Finance

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

eMolecules acquires Specs Compound Handling B.V.

bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows

H.E.L Group makes senior appointments as it continues to scale globally

LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

Vector Biolabs expands viral vector manufacturing capacity and adds to QC capabilities

Cytiva and Pall Life Sciences complete integration to create a global innovation and solutions leader in biotechnology

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Global Access Diagnostics (GADx) welcomes new leadership

CELLINK Unveils Third Generation LUMEN X – The New Standard for DLP Bioprinting

Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors

MGI and South Australian Genomics Centre Introduce DNBSEQ-T7 to Supercharge Genomics Research in Australia

MGI Announces New Customer Experience Center in South Korea with BMS

MGI Secured First Corporate Order of Ultra-high Throughput Sequencer DNBSEQ-T20×2*

INTEGRA Biosciences’ new eBook: all you need to know about ELISAs

FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform Portfolio for Bioprocessing

Bedfont® Scientific Ltd. achieves Platinum Business Award presented by Kent County Council (KCC)

Flow Robotics takes sample traceability to the next level

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News